Neurodegeneration, a progressive decline in the functionality of nerves, presents a daunting challenge to modern medicine. While there is currently no solution for neurodegenerative diseases, researchers are vigorously exploring innovative therapeutic approaches. One such avenue of research involves deschloroketamine, a derivative of the anesthetic